Skip to content
10-Q

Quarterly Report

CytomX Therapeutics, Inc. CTMX

0001193125-25-269477

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 169.44M sh
Shares Diluted Q3 2025 · Sep 30, 2025 165M sh
Shares Diluted Q3 2025 · Sep 30, 2025 128.86M sh
Shares Diluted Q3 2025 · Sep 30, 2024 85.2M sh
Shares Diluted Q3 2025 · Sep 30, 2024 84.43M sh
Capex Q3 2025 · Sep 30, 2025 $19K
Capex Q3 2025 · Sep 30, 2024 $230K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$52.34M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$66.32M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $34.19M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $38.05M
Stockholders Equity Q3 2025 · Sep 30, 2025 $107.39M
Stockholders Equity Q3 2025 · Jun 30, 2025 $119.91M
Stockholders Equity Q3 2025 · Mar 31, 2025 $25.05M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$456K
Stockholders Equity Q3 2025 · Sep 30, 2024 −$23.45M
Stockholders Equity Q3 2025 · Jun 30, 2024 −$31.23M
Stockholders Equity Q3 2025 · Mar 31, 2024 −$31.68M
Stockholders Equity Q3 2025 · Dec 31, 2023 −$47.45M
Current Liabilities Q3 2025 · Sep 30, 2025 $41.03M
Current Liabilities Q3 2025 · Dec 31, 2024 $85.77M
Total Liabilities Q3 2025 · Sep 30, 2025 $50.87M
Total Liabilities Q3 2025 · Dec 31, 2024 $120.99M
Current Assets Q3 2025 · Sep 30, 2025 $149.22M
Current Assets Q3 2025 · Dec 31, 2024 $107.31M
Total Assets Q3 2025 · Sep 30, 2025 $158.25M
Total Assets Q3 2025 · Dec 31, 2024 $120.53M
Sga Expense Q3 2025 · Sep 30, 2025 $6.43M
Sga Expense Q3 2025 · Sep 30, 2025 $22.48M
Sga Expense Q3 2025 · Sep 30, 2024 $7.95M
Sga Expense Q3 2025 · Sep 30, 2024 $24.1M
Rd Expense Q3 2025 · Sep 30, 2025 $15.3M
Rd Expense Q3 2025 · Sep 30, 2025 $47.49M
Rd Expense Q3 2025 · Sep 30, 2024 $21.37M
Rd Expense Q3 2025 · Sep 30, 2024 $68.59M
Net Income Q3 2025 · Sep 30, 2025 −$14.23M
Net Income Q3 2025 · Sep 30, 2025 $9.14M
Net Income Q3 2025 · Jun 30, 2025 −$154K
Net Income Q3 2025 · Mar 31, 2025 $23.53M
Net Income Q3 2025 · Sep 30, 2024 $5.74M
Net Income Q3 2025 · Sep 30, 2024 $12.99M
Net Income Q3 2025 · Jun 30, 2024 −$6.53M
Net Income Q3 2025 · Mar 31, 2024 $13.79M
Operating Income Q3 2025 · Sep 30, 2025 −$15.77M
Operating Income Q3 2025 · Sep 30, 2025 $5.57M
Operating Income Q3 2025 · Sep 30, 2024 $4.11M
Operating Income Q3 2025 · Sep 30, 2024 $7.32M
Revenue Q3 2025 · Sep 30, 2025 $5.96M
Revenue Q3 2025 · Sep 30, 2025 $75.54M
Revenue Q3 2025 · Sep 30, 2024 $33.43M
Revenue Q3 2025 · Sep 30, 2024 $100.01M